← PUMA BIOTECHNOLOGY, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ($276.0m) | ($292.0m) | ($113.6m) | ($75.6m) | ($60.0m) | ($29.1m) | $2k | $21.6m | $30.3m | $31.1m | — | |
| Depreciation and amortization | $1.1m | $2.8m | $7.4m | $8.1m | $10.0m | $10.6m | $8.9m | $11.5m | $11.5m | $10.9m | $10.5m | |
| Depreciation | $1.1m | $2.8m | $7.4m | $900k | $900k | $700k | $600k | $400k | $400k | $400k | $10.5m | |
| Amortization of Debt Issuance Costs | — | — | — | — | $2.0m | $2.6m | $1.2m | $1.3m | — | — | — | |
| Amortization of Intangible Assets | — | $1.6m | $3.9m | $3.9m | $6.3m | $8.0m | $8.0m | $9.7m | $9.7m | $9.7m | — | |
| Deferred Income Tax Expense (Benefit) | — | — | — | — | — | — | — | $0 | ($7.1m) | $3.2m | $3.2m | |
| Share-based Payment Arrangement, Noncash Expense | $117.3m | $108.7m | $86.9m | $57.3m | $36.6m | $32.6m | $11.8m | $10.2m | $8.2m | $6.9m | $7.1m | |
| Share-based Payment Arrangement, Expense | — | — | — | — | — | $32.6m | $11.8m | $10.2m | $8.2m | $6.9m | $7.1m | |
| Stock-based compensation | $117.3m | $108.7m | $86.9m | $57.3m | $36.6m | $32.6m | $11.8m | $10.2m | $8.2m | $6.9m | $7.1m | |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | — | — | ($1.2m) | — | — | — | — | — | — | — | |
| Operating Lease, Impairment Loss | — | — | — | — | — | $0 | $0 | — | — | — | — | |
| Loss on impairment of asset | — | — | — | $1.2m | $0 | $0 | $0 | $625k | $0 | $0 | — | |
| Nonoperating Income (Expense) | $585k | $435k | ($18.9m) | ($36.5m) | ($29.4m) | ($30.1m) | ($23.3m) | ($10.0m) | ($6.9m) | ($1.5m) | — | |
| Other Nonoperating Income (Expense) | ($373k) | ($101k) | ($714k) | $128k | $367k | $292k | ($28k) | $759k | $862k | $1.0m | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | $9.7m | $11.1m | $8.1m | ($2.4m) | $6.0m | $7.8m | $8.4m | ($16.3m) | $21.3m | ($7.9m) | |
| Accounts receivable, net | — | ($9.7m) | ($11.1m) | ($8.1m) | $2.4m | ($6.0m) | ($7.8m) | ($8.4m) | $16.3m | ($21.3m) | ($7.9m) | |
| Increase (Decrease) in Inventories | — | $2.0m | $596k | $545k | $284k | $3.7m | ($2.6m) | $2.6m | $1.6m | ($3.2m) | ($4.7m) | |
| Inventory, net | — | ($2.0m) | ($596k) | ($545k) | ($284k) | ($3.7m) | $2.6m | ($2.6m) | ($1.6m) | $3.2m | ($4.7m) | |
| Increase (Decrease) in Accounts Payable | $2.2m | $7.7m | ($7.0m) | ($1.5m) | ($7.1m) | ($902k) | ($4.7m) | $449k | ($1.4m) | ($453k) | ($2.3m) | |
| Accrued expenses and other | — | — | $15.8m | $22.6m | $19.3m | $5.2m | ($33.1m) | ($7.6m) | ($15.8m) | $13.2m | — | |
| Other current assets | — | — | ($1.8m) | $1.5m | ($3.1m) | $3.2m | ($2.0m) | $1.5m | $821k | ($165k) | ($126k) | |
| Net Cash Provided by (Used in) Operating Activities | ($141.7m) |
($172.5m)
-21.72%
|
($24.1m)
+86.02%
|
$22.4m
+192.83%
|
$773k
-96.55%
|
$20.6m
+2571.41%
|
($15.8m)
-176.64%
|
$27.0m
+270.65%
|
$38.9m
+44.09%
|
$41.8m
+7.41%
|
$41.1m
-1.56%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $4.3m | $431k | $439k | $25k | ($46k) | $0 | $0 | $140k | $56k | $71k | ($71k) | |
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | — | ($54k) | $0 | ($1k) | ($1k) | $0 | $0 | ($4k) | $4k | |
| Cash, Cash Equivalents, and Short-term Investments | $229.4m | $81.7m | — | — | — | $69.8m | $46.5m | $48.9m | $86.8m | $91.6m | — | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | — | — | — | $104.5m | $73.3m | $27.2m | $18.9m | $17.3m | $55.8m | $72.0m | — | |
| Net Cash Provided by (Used in) Investing Activities | $142.2m | ($15.4m) | ($57.6m) | $5.2m | $23.4m | ($10.9m) | $7.1m | ($19.1m) | ($20.4m) | ($36.2m) | ($16.0m) | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | — | — | — | ($8.0m) | — | ($8.1m) | $0 | $0 | — | — | — | |
| Proceeds from Issuance of Long-term Debt | — | $50.0m | $105.0m | $25.0m | — | — | — | — | — | — | — | |
| Payment of debt | — | — | — | ($80.0m) | ($8.4m) | ($100.0m) | $0 | $0 | ($33.3m) | ($44.4m) | — | |
| Proceeds from Issuance of Common Stock | $161.9m | — | — | — | — | — | — | — | — | — | $0 | |
| Net Cash Provided by (Used in) Financing Activities | $162.4m |
$75.1m
-53.76%
|
$108.5m
+44.39%
|
($67.1m)
-161.84%
|
$68k
+100.10%
|
($31.9m)
-47057.35%
|
$12.2m
+138.28%
|
$0
-100.00%
|
($33.8m) |
($45.2m)
-33.54%
|
($45.3m)
-0.31%
|
|
| Net (decrease) increase in cash, cash equivalents and restricted cash | $162.9m | ($112.8m) | $26.7m | ($39.5m) | $24.2m | ($22.2m) | $3.5m | $7.9m | ($15.4m) | ($39.6m) | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | $26.7m | ($39.5m) | $24.2m | ($22.2m) | $3.5m | $7.9m | ($15.4m) | ($39.6m) | $36.5m | |
| Cash, cash equivalents and restricted cash, beginning of period | $198.8m | $86.0m | $112.7m | $73.2m | $97.5m | $75.3m | $78.8m | $86.7m | $71.3m | $31.7m | — | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $576k | — | — | — | — | — | — | — | — | — | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | $334k | $8.1m | $11.7m | $9.7m | $10.3m | $10.3m | $11.6m | $10.8m | $5.8m | — | |
| Income Taxes Paid, Net | — | — | $17k | $53k | $207k | $324k | $384k | $737k | $1.2m | $1.3m | — | |
| Additional Financial Items | ||||||||||||
| Gain (Loss) on Disposition of Assets | ($368k) | — | — | — | — | — | — | — | — | — | — | |
| General and Administrative Expense | $53.8m | — | — | — | — | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $0 | $0 | $17k | $53k | $207k | $324k | $455k | $1.1m | ($6.2m) | $4.7m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $12.5m | $6.6m | — | |
| Investment Income, Interest | $958k | $1.3m | $1.8m | $2.8m | $489k | $160k | $813k | $2.6m | $4.7m | $4.1m | — | |
| Operating Expenses | $276.6m | $320.1m | $345.7m | $311.4m | $255.5m | — | — | — | — | — | — | |
| Operating Lease, Expense | — | — | — | — | — | $5.1m | $4.9m | $4.9m | $4.9m | $4.5m | — | |
| Provision for credit loss recovery | — | — | — | $0 | $1.0m | $0 | $0 | $881k | ($519k) | ($362k) | — | |
| Prepaid expenses and other | $3.4m | ($1.1m) | ($840k) | $568k | $2.3m | $2.7m | $2.4m | $820k | $1.0m | ($325k) | — | |
| Operating lease assets and liabilities, net | — | — | — | — | — | ($707k) | ($920k) | ($1.2m) | ($1.6m) | ($1.8m) | — | |
| Post-marketing commitment liability | — | — | — | $9.0m | ($140k) | ($1.1m) | ($921k) | ($940k) | ($1.3m) | ($2.4m) | — | |
| Purchase of available-for-sale securities | ($81.8m) | ($79.7m) | ($107.5m) | ($127.2m) | ($29.8m) | ($38.1m) | ($4.8m) | ($23.8m) | ($76.2m) | ($108.1m) | — | |
| Maturity of available-for-sale securities | — | $114.7m | $50.5m | $104.5m | $73.3m | $27.2m | $18.9m | $17.3m | $55.8m | $72.0m | — | |
| Purchase of intangible assets | — | ($50.0m) | — | $0 | ($20.0m) | $0 | $0 | ($12.5m) | $0 | $0 | — | |
| Net proceeds from shares issued under employee stock plans | $576k | $26.7m | $7.7m | $1.4m | $68k | $0 | $0 | $0 | $150k | $130k | — | |
| Payment of exit costs | — | — | — | ($7.8m) | — | — | $0 | $0 | ($666k) | ($888k) | — |